Phase I human tolerability trial of aildenafil citrate tablet

作者
Yanhong Liu
出处
期刊:Chinese Journal of New Drugs [Chinese Journal of New Drugs Co. Ltd.]
摘要

Objective: To assess the tolerability and safety of aildenafil citrate tablet in healthy Chinese male volunteers.Methods: Twenty-eight healthy Chinese male subjects were recruited to the single dose study.They were divided into 30,60,90 and 120 mg dose step with 30 mg as the first dose step;safety and tolerability findings at the previous dose level were the basis for the decision to proceed to the next higher dose level.Thirty-six healthy Chinese male subjects were enrolled to the multiple dose study,and the escalated dose level were 30,45 and 60 mg·d-1,once daily for continuous 3 days.The safety was assessed based on clinical symptoms and adverse events.Results: In the single dose study,the adverse events judged by the investigator to be related to aildenafil citrate tablet were abnormal vision(35.7%),flushing(21.4%),headache or dizziness(17.9%).In the multiple dose study,the adverse events related to aildenafil citrate tablet were flushing(7.4%),headache or dizziness(7.4%).There were no serious adverse events;all adverse events were mild in severity and resolved without any treatment.There were no clinically significant changes in vital signs,clinical laboratory tests and ophthalmological examination.Conclusion: Aildenafil citrate tablet is safe and well-tolerated in Chinese male healthy subjects after single doses of 30~120 mg and multiple doses of 30~60 mg,qd for 3 days.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HHH完成签到,获得积分10
刚刚
mm发布了新的文献求助10
刚刚
刚刚
香蕉觅云的应助被聪明冰蓝采纳,获得10
刚刚
要减肥含灵完成签到,获得积分10
刚刚
刚刚
六神曲完成签到,获得积分10
1秒前
1秒前
夕沫完成签到,获得积分10
2秒前
火星上静竹完成签到,获得积分10
2秒前
呼啦啦完成签到,获得积分10
2秒前
3秒前
4秒前
Maestro_S的应助被鲤鱼鑫磊采纳,获得10
4秒前
YXY完成签到,获得积分10
4秒前
顾矜的应助被zyy采纳,获得10
5秒前
冰糖葫芦发布了新的文献求助10
5秒前
传奇3的应助被包bao采纳,获得10
6秒前
6秒前
6秒前
无极微光的应助被keke采纳,获得20
7秒前
rainbow发布了新的文献求助10
7秒前
Ya_Yen发布了新的文献求助10
7秒前
七七酱发布了新的文献求助10
8秒前
8秒前
8秒前
salda_ssibal完成签到,获得积分10
8秒前
9秒前
9秒前
9秒前
默listening完成签到,获得积分10
9秒前
9秒前
10秒前
10秒前
翻斗花园李元芳完成签到,获得积分10
10秒前
10秒前
漆漆发布了新的文献求助10
11秒前
漆漆发布了新的文献求助10
11秒前
大个的应助被mm采纳,获得10
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820